Keyphrases
Randomized Controlled Trial
100%
Suicidal Ideation
100%
Time-limited Therapy
100%
Ultra-low Dose
100%
Buprenorphine
100%
Sublingual Buprenorphine
50%
Placebo
33%
Substance Abuse
33%
Suicidal Patients
33%
Antidepressants
16%
Randomized Placebo-controlled Trial
16%
Borderline Personality Disorder
16%
Experimental Therapeutics
16%
Pharmacological Treatment
16%
Patient Demographics
16%
Suicidal Behavior
16%
Twice Daily
16%
Suicidality
16%
Once-daily
16%
Individual Treatment
16%
Mental Pain
16%
Initial Dose
16%
Concurrent Use
16%
Safety Self-efficacy
16%
Endogenous Opioids
16%
Adjunctive Therapy
16%
Withdrawal Syndrome
16%
Treatment Discontinuation
16%
Separation Distress
16%
Outpatient Use
16%
Psychology
Pharmacological Treatment
100%
Separation Distress
100%
Endorphin
100%
Borderline Personality Disorder
100%
Withdrawal Symptom
100%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Randomized Controlled Trial
100%
Buprenorphine
100%
Endorphin
14%
Neuroscience
Randomized Controlled Trial
100%
Buprenorphine
100%
Placebo
42%
Antidepressant
14%
Borderline Personality Disorder
14%
Withdrawal Syndrome
14%
Endorphin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Buprenorphine
100%
Placebo
42%
Antidepressant
14%
Withdrawal Syndrome
14%
Endorphin
14%
Borderline State
14%
Immunology and Microbiology